We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
The characteristics, diagnosis, management and epidemiology of necrotising fasciitis (NF).
How to spot dourine, what to do if you suspect it and measures to prevent its spread.
How to spot Batrachochytrium salamandrivorans, what to do if you suspect it and measures to prevent its spread.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
You may need to tell DVLA if you have cancer - if you do, download the correct form to let them know
The characteristics, diagnosis, management, surveillance and epidemiology of CJD.
Quarterly updates to the emergency presentations of cancer data by Public Health England.
The epidemiology, management and prevention of genital warts and human papillomavirus (HPV).
Find out about the long-term effects some people can have after having COVID-19.
The characteristics, diagnosis, epidemiology of hantaviruses.
A detailed explanation of the link between human papillomavirus (HPV) and cervical cancer, as evidence for the NHS cervical screening programme.
Information on ionising radiation damage and cancer risks.
How to spot Echinococcus multilocularis, what to do if you suspect it and how to prevent its spread.
Information on the risks from low levels of ionising radiation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.